Posted on:
We may soon have a convenient and painless approach to diagnose chronic kidney disease following research by the team from the Kolling Institute’s Renal Research Laboratory. Chronic kidney disease is an emerging global health issue, currently affecting more than 11 per cent of Australians and 13 per cent of the worldwide population. By 2032, it’s…
Posted on:
Our Kolling Institute Year in Review profiles our innovative and life-changing research across the Kolling Institute. Our researchers are driving investigations into some of the most challenging health conditions from heart and kidney disease to musculoskeletal conditions, chronic pain, cancer and neurodegenerative disorders. Our teams have continued to increase their research impact, while forging significant new collaborations. They…
Posted on:
Our ground-breaking leukaemia research at the Kolling Institute has received an important boost with the Cancer Council NSW announcing a $450,000 grant for Associate Professor Jenny Wang and her research team. The funds will help the development of a new therapy to greatly improve survival rates for those with acute myeloid leukaemia. This form of…
Posted on:
A team of researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research has launched a study to develop the first internationally accepted guidelines for assessing cognitive function after a spinal cord injury. The latest data indicates that over 15 million people globally live with a spinal cord injury, and in Australia, there are…
Posted on:
A culture of collaboration is a key part of the Kolling Institute’s research impact, and just one example of this is a joint project to reduce the devastating impact of vascular disease linked to diabetes. The study has brought together research experts from endocrinology and cardiology to curb the number of lower limb amputations due…
Posted on:
While there has been a great deal of encouraging progress with many cancer treatments over the last decade, the prognosis for people with acute myeloid leukaemia remains dismal, with only 27 per cent of patients surviving more than five years after treatment. Lead researcher Dr Jenny Wang said we have seen a sharp rise in…
Posted on:
It is with great sadness that the Kolling Institute acknowledges the passing of Professor John Walsh AO. Professor Walsh had a longstanding relationship with many researchers across the Kolling and the local health district and was immensely respected by his colleagues. Having a background as an actuary, Professor Walsh applied his expertise to many projects…
Posted on:
Less than two years after a breast cancer diagnosis, Professor Gemma Figtree has completed the prestigious Boston Marathon while raising significant funds for cancer research. Gemma crossed the finish line in a sub four hour time as part of the talented team running for the internationally renowned Dana Farber Cancer Institute. Gemma ran her first…
Posted on:
Leading researchers from the Kolling Institute have welcomed the opportunity to collaborate with Metakosmos as it pioneers the development of a next-generation space suit. Led by CEO Kiriti Rambhatla, Metakosmos is working to revolutionise human spaceflight technology. Their Kosmosuit architecture has garnered acclaim and the interest of the Kolling Institute’s Academic Director Professor James Elliott.…
Posted on:
We would like to congratulate our early career researcher Dr Nashwa Masnoon from the Kolling’s Ageing and Pharmacology Lab who has taken out the ATA Scientific Young Scientist Encouragement Award. Nashwa, who is a postdoctoral research pharmacist, clinched the $1500 prize for her assessment of the risks and benefits of using artificial intelligence in research.…
Copyright © 2026 Kolling Institute
All rights reserved